New York City mayoral candidate Zohran Mamdani told business leaders that he would begin to discourage the use of the phrase ...

CEO Albert Bourla said the vaccine remains protective against hospitalizations and deaths, but "doesn't last very long" for warding off infections.

Zohran Mamdani told a group of top business leaders in New York City on Tuesday that he would discourage the use of the ...

Pfizer CEO Albert Bourla delivers a speech during the inauguration ceremony of the company's new center for Digital Innovation and Business Operations and Services in Thessaloniki, Greece.

Full interview: Pfizer CEO Albert Bourla on “Face the Nation” 42:50 The following is a full transcript of an interview with Pfizer CEO Albert Bourla that aired Sunday, March 13, 2022, on "Face ...

Albert Bourla at the New York Stock Exchange in 2019. Drew Angerer/Getty Images. As the CEO of Pfizer, Albert Bourla made headlines for his professional accomplishments, leading the pharmaceutical ...

P fizer CEO Albert Bourla has accomplished in 11 months what usually takes years, with the company’s Covid-19 vaccine ready to hit the market in record time. Bourla told the 2020 Forbes ...

Pfizer CEO Albert Bourla cashed in on his company’s coronavirus vaccine breakthrough. The executive sold more than $5.5 million worth of Pfizer stock on Monday — the same day the drugmaker sa… ...

Pfizer CEO Albert Bourla said Monday he hasn't taken the COVID-19 vaccine yet -- but only because he doesn't want to be seen as jumping the line.

Pfizer’s CEO, Albert Bourla, revealed he has finally received the first round of a two-dose treatment developed by his pharmaceutical company to protect against COVID-19.

Pfizer CEO Albert Bourla on Tuesday said the company hopes to know whether it will be able to have a safe and effective coronavirus vaccine by the end of October. “When the study will read out ...

Pfizer Inc. paid Chief Executive Officer Albert Bourla $21 million in total compensation last year, as the pharmaceutical giant became the first to gain U.S. authorization for a coronavirus vaccine.